• 10/2005 – 07/2011: MD, 1st Medical School at the Charles University, Prague, Czech Republic (MUDr)
• 07/2015: Certificate “Application of Low level Laser Therapy/Photobiomodulation Therapy” -Thor® Company
• 05/2017: Board Certification Exam in Radiation Oncology (Germany)
• 02/2018: Doctorate at Goethe University Frankfurt, Germany - Topic: “HDR-Brachytherapy as monotherapy for patients with localized prostate cancer”

• 08/2011 – 03/2012: Department of General Surgery, Famagusta General Hospital, Pre-registration physician
• 01/2013 – 12/2013: Radiation Oncology Department, Klinikum Chemnitz GmbH, Germany – Radiation Oncology Resident
• 01/2014 – 09/2016: Department of Interdisciplinary Oncology, Sana Klinikum Offenbach Germany – Radiation Oncology Resident
• 09/2016 –  08/2018: Department of Radiation Oncology, University Clinic Freiburg, Medical Center, Germany – Radiation Oncology Resident
• 05/2018 – 08/2018: Department of Radiation Oncology, University Clinic Freiburg, Medical Center, Germany – Radiation Oncology Consultant
• 08/2018 till today: Department of Radiation Oncology, German Oncology Center, Limassol, Cyprus –Radiation Oncology Consultant

• 12/2015 Educational training “Radiotherapy for malignant disorders in childhood”, West-Germany Proton Center, Essen, Germany
• 04/2016 Special training course “Partial breast Irradiation with interstitial brachytherapy”, Erlangen, Germany
• 02/2020 ESTRO Training course on Comprehensive and Practical Brachytherapy (IAEA grant), Brussels, Belgium

• Jul. 2015: Certificate „Application of Low level Laser Therapy“ – Thor® Company
• Nov.2014 – Feb. 2018: Doctorate, Goethe University Frankfurt – Topic: “HDR-brachytherapy as monotherapy in patients with localized prostate cancer”
• 01 – 07/2016: Lecturer, Sana Klinikum Offenbach, Germany, School for Radiographers
• 10/2016: Lecturer, Medical Center – University of Freiburg, Medical students
• 02/2017: Certificate of “Good Clinical Practice” – GCP as “Primary Investigator”
• Since 09/2016 Active involvement in national/European and international prospective studies
• 09/2016 – 07/2018: Researcher at the Study Group of the Department of Radiation Oncology, University Clinic Freiburg, Medical Center, Germany
• Since 2018: Member of UroGEC group (Groupe Européen de Curiethérapie (GEC) of European Society of Radiotherapy & Oncology (ESTRO))

• ESTRO (European Society for Radiotherapy and Oncology)
• UroGEC of ESTRO (Groupe Européen de Curiethérapie (GEC) of European Society of Radiotherapy & Oncology (ESTRO))
• OEK (Cyprus Oncologic Society)
• DEGRO (German Society for Radiation Oncology)

• Peer- Reviewed Publications
• Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation …, International Journal of Radiation Oncology, Biology, Physics 113 (5), 1015-1024
• 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization S Zschaeck, J Weingärtner, E Lombardo, S Marschner, M Hajiyianni, I Strouthos, Frontiers in oncology 12, 870319
• Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy C Zamboglou, I Strouthos, J Sahlmann, et al. International Journal of Radiation Oncology* Biology* Physics
• Physical characterisation of commercial ear impression materials for use as a bolus in radiotherapy,  P Doolan, G Antorkas, A Hadjipanteli, K Ferentinos, N Zamboglou, I Strouthos, Physica Medica: European Journal of Medical Physics 92, S63
• Metastasis-free survival after salvage radiotherapy for post-operative prostate cancer patients in the PSMA PET/CT era–a multicenter analysis, C Zamboglou, NS Schmidt-Hegemann, L Emmett, I Strouthos, European Urology Open Science 33, S261-S262
• Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer, G Chatzikonstantinou, I Strouthos, C Scherf, J Köhn, C Solbach, C Rödel, Journal of Radiation Research 62 (3), 465-472
• Intraluminal High-Dose-Rate Brachytherapy—An Alternative Organ-Preserving Approach for Primary Male Urothelial Carcinoma With Panurethral Involvement, I Strouthos, N Tselis, K Ferentinos, E Karagiannis, N Milickovic, ..., Practical Radiation Oncology 10 (1), e53-e56
• Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme, G Chatzikonstantinou, P Ulrich, E Archavlis, N Zamboglou, I Strouthos, ..., Journal of Contemporary Brachytherapy 11 (3), 215-220
• Repeated SBRT for in-and out-of-field recurrences in the liver, E Gkika, I Strouthos, S Kirste, S Adebahr, M Schultheiss, D Bettinger, ..., Strahlentherapie und Onkologie 195 (3), 246-253
• Outcome after PSMA PET/CT–based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a 2-institution retrospective analysis, NS Schmidt-Hegemann, C Stief, TH Kim, C Eze, S Kirste, I Strouthos, M Li, ..., Journal of Nuclear Medicine 60 (2), 227-233
• CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience, G Chatzikonstantinou, N Zamboglou, E Archavlis, I Strouthos, E Zoga, ...,Strahlentherapie und Onkologie 194 (12), 1171-1179
• Inverse planning and inverse implanting for breast interstitial brachytherapy. Introducing a new anatomy specific breast interstitial template (ASBIT), E Karagiannis, A Leczynski, N Tselis, E Psanis, O Steckenreiter, I Strouthos, N Zamboglou, Radiotherapy and Oncology 128 (3), 421-427
• Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer, I Strouthos, G Chatzikonstantinou, N Zamboglou, N Milickovic, N Tselis, Radiotherapy and Oncology 128 (2), 301-307
• High dose rate brachytherapy as monotherapy for localised prostate cancer, I Strouthos, N Tselis, G Chatzikonstantinou, S Butt, D Baltas, D Bon, ... ,Radiotherapy and Oncology 126 (2), 270-277
• CT-Guided Interstitial HDR-Brachytherapy for Recurrent Glioblastoma Multiforme: Twenty Years Single-Institute Experience, G Chatzikonstantinou, E Archavlis, I Strouthos, E Zoga, N Milickovic, ... 
• Photobiomodulation therapy for the management of radiation-induced dermatitis, I Strouthos, G Chatzikonstantinou, N Tselis, D Bon, E Karagiannis, E Zoga, ... Strahlentherapie und Onkologie 193 (6), 491-498
• Radiation recall dermatitis: case report I Strouthos, Reactions 1625, 86-29
• Docetaxel-induced radiation recall dermatitis, I Strouthos, N Tselis, N Zamboglou Strahlentherapie und Onkologie 192 (10), 730-736, 62016

Abstracts

• 06/2022: Metastasis-free Survival and Distant Metastasis Patterns after PSMA-PET-guided Salvage Radiotherapy for recurrent or persistent Prostate Cancer after Prostatectomy C Zamboglou, I Strouthos, S Adebahr et al. Strahlentherapie und Onkologie 198 (SUPPL 1), S117-S117
• 05/2022: Hypofractionated prostate radiotherapy: alternate delineation approach vs validated trial protocol, I Strouthos, E Karagiannis, P Doolan, et al. Radiotherapy and Oncology 170, S1180-S1181
• 05/2022: Implementation of high-dose-rate brachytherapy as monotherapy for over-sized prostatic gland Y Roussakis, G Antorkas, A Antoniou, C Cloconi, E Karagiannis, I Strouthos,  Radiotherapy and Oncology 170, S265
• 03/2022: Early Detection of Acute Radiation Dermatitis (ARD) Using In Vivo Optical Coherence Tomography (OCT) Images, C Photiou, I Strouthos, C Cloconi, Optical Coherence Tomography, CM2E. 4
• 03/2022: In vivo early detection of acute radiation dermatitis using optical coherence tomography (OCT) images, C Photiou, I Strouthos, C Cloconi, Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XXVI, 1194808
• 10/2021: Automatic segmentation of prostate on TRUS images using convolutional neural networks, F Paskali, T Fechter, C Zambgolou, I Strouthos, L Georgiou, D Baltas, Physica Medica: European Journal of Medical Physics 92, S198
• 05/2021: A comparison of three commercial AI contouring solutions, P Doolan, S Charalambous, Y Roussakis, A Leczynski, K Ferentinos, I Strouthos, E Karagiannis,  Radiotherapy and Oncology 161, S1221-S1222
• 05/21: Interstitial multicatheter High-Dose-Rate Brachytherapy as adjuvant accelerated Partial Breast Irradiation after repeated Breast-conserving Therapy in Patients with ipsilateral …,G Chatzikonstantinou, I Strouthos, C Scherf, J Koehn, C Solbach, Strahlentherapie und Onkologie 197 (SUPPL 1), S54-S55
• 05/2021: Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/-CT era-a tri-institutional, retrospective analysis, C Zamboglou, I Strouthos, AL Grosu, S Kirste, K Ferentinos, J Ruf, ..., STRAHLENTHERAPIE UND ONKOLOGIE 197 (SUPPL 1), S13-S14
• 05/2021: HEPANOVA: a phase 2 trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma, AL Grosu, I Strouthos, E Gkika, T Brunner, U Weinberg, A Kinzel, STRAHLENTHERAPIE UND ONKOLOGIE 195, S104-S104
• 06/2018: The Role of local curative Therapy in oligometastatic NSCLC, E Gkika, D Schiebahn, A Bunea, H Bunea, T Schimek-Jasch, S Adebahr, I Strouthos ...,STRAHLENTHERAPIE UND ONKOLOGIE 194, S80-S80
• 06/2018: The Role of FDG PET/CT in SBRT of primary Tumors in the Upper Abdomen, E Gkika, N Bartl, I Strouthos, S Adebahr, S Kirste, I Popp, H Schaefer, ..., STRAHLENTHERAPIE UND ONKOLOGIE 194, S88-S89
• 06/2018: The prognostic Significance of the Neutrophil/Lymphocyte Ratio in the SBRT of cholangiocellular Carcinomas, E Gkika, N Bartl, I Strouthos, S Adebahr, I Popp, H Schaefer, AL Grosu, ..., STRAHLENTHERAPIE UND ONKOLOGIE 194, S104-S105
• 06/2018: High dose rate brachytherapy boost plus external beam radiotherapy for high risk localized prostate cancer, I Strouthos, G Chatzikonstantinou, N Milickovic, S Papaioannou, ... STRAHLENTHERAPIE UND ONKOLOGIE 194, S20-S20
• 06/2018: Evaluation of simultaneously integrated Protection (SIP) in the Upper Abdomen SBRT, E Gkika, I Strouthos, N Bartl, I Popp, S Adebahr, S Kirste, H Schaefer, .., STRAHLENTHERAPIE UND ONKOLOGIE 194, S105-S105
• 05/2018: Interobserver and interfraction variability using free-breathing cbCT for SBRT of the upper abdomen, L Nicosia, T Brunner, I Popp, E Gkika, F Capilli, HC Rischke, I Strouthos ..., Radiotherapy and Oncology 127, S790-S791
• 05/2018: Safety of repeated stereotactic body radiotherapy (SBRT) for recurrent liver malignancies, E Gkika, I Strouthos, S Adebahr, S Kirste, D Bettinger, R Fritsch, V Brass, ..., Radiotherapy and Oncology 127, S778-S779
• 05/2018: High dose rate brachytherapy plus external beam radiotherapy for localized prostate cancer, I Strouthos, G Chatzikonstantinou, N Tselis, N Milickovic, S Papaioannou, ..., Radiotherapy and Oncology 127, S427
• 06/2017: Photobiomodulation therapy for the management of radiation-induced dermatitis: a single-institution experience during adjuvant radiotherapy in breast cancer patients after …, I Strouthos, G Chatzikonstantinou, E Karagiannis, E Zoga, K Ferentinos, .., STRAHLENTHERAPIE UND ONKOLOGIE 193, S168-S169
• 06/2017: High dose rate brachytherapy as monotherapy for organ confined prostate cancer: a three-implant-three-fraction approach in 450 consecutive patients, I Strouthos, N Tselis, G Chatzikonstantinou, S Butt, D Baltas, N Milickovic, ... STRAHLENTHERAPIE UND ONKOLOGIE 193, S135-S135
• 06/2017: Inverse planning for breast interstitial brachytherapy. Introducing a new Anatomy Specific Breast Interstitial Template (ASBIT), E Karagiannis, A Leczynski, N Tselis, E Psanis, O Steckenreiter, I Strouthos ... STRAHLENTHERAPIE UND ONKOLOGIE 193, S30-S31

• Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors, E Karagiannis, I Strouthos, A Leczynski, N Zamboglou, K Ferentinos, Frontiers in Oncology
• High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome, I Strouthos, E Karagiannis, N Zamboglou, K Ferentinos, Cancer Reports 5 (1), e1450
• Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature, K Ferentinos, E Karagiannis, I Strouthos, A Vrachimis, PJ Doolan, Brachytherapy 20 (4), 892-899
• High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy G Chatzikonstantinou, N Zamboglou, C Rödel, E Zoga, I Strouthos, ..., Strahlentherapie und Onkologie 193 (9), 683-691